Methods |
Randomised controlled trial. No information given on method of randomisation
Blinding not mentioned
No loss to follow‐up |
Participants |
30 patients undergoing coronary artery operations. Patients were excluded if they had undergone previous cardiac operations, if they had severe coagulopathies, anaemia, or CRF |
Interventions |
1) 6% HES (n = 15)
2) 5% Albumin (n = 15)
Both fluids infused over 24 hours to maintain left arterial pressure between 6 mmHg and 12 mmHg and cardiac index > 2.0 L/minute/m2
|
Outcomes |
Death
Haemodynamic and coagulation variables
Adverse reactions |
Notes |
Follow‐up until discharge from ICU
34 patients were originally included in the trial but data from 4 of them was not included in the final analysis |
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Allocation concealment (selection bias) |
Unclear risk |
Unclear. No information given on allocation concealment |